198 related articles for article (PubMed ID: 10720270)
21. Dynamic properties of horizontal and vertical eye movements in parkinsonian syndromes.
Rottach KG; Riley DE; DiScenna AO; Zivotofsky AZ; Leigh RJ
Ann Neurol; 1996 Mar; 39(3):368-77. PubMed ID: 8602756
[TBL] [Abstract][Full Text] [Related]
22. Progressive Supranuclear Palsy, Corticobasal Degeneration, and Multiple System Atrophy.
Greene P
Continuum (Minneap Minn); 2019 Aug; 25(4):919-935. PubMed ID: 31356287
[TBL] [Abstract][Full Text] [Related]
23. Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy.
Josephs KA; Duffy JR
Curr Opin Neurol; 2008 Dec; 21(6):688-92. PubMed ID: 18989114
[TBL] [Abstract][Full Text] [Related]
24. Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy.
Soliveri P; Monza D; Paridi D; Radice D; Grisoli M; Testa D; Savoiardo M; Girotti F
Neurology; 1999 Aug; 53(3):502-7. PubMed ID: 10449111
[TBL] [Abstract][Full Text] [Related]
25. Visual event-related potentials in progressive supranuclear palsy, corticobasal degeneration, striatonigral degeneration, and Parkinson's disease.
Wang L; Kuroiwa Y; Kamitani T; Li M; Takahashi T; Suzuki Y; Shimamura M; Hasegawa O
J Neurol; 2000 May; 247(5):356-63. PubMed ID: 10896267
[TBL] [Abstract][Full Text] [Related]
26. Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration.
Litvan I; Grimes DA; Lang AE; Jankovic J; McKee A; Verny M; Jellinger K; Chaudhuri KR; Pearce RK
J Neurol; 1999 Sep; 246 Suppl 2():II1-5. PubMed ID: 10525996
[TBL] [Abstract][Full Text] [Related]
27. Long-term locomotor training for gait and balance in a patient with mixed progressive supranuclear palsy and corticobasal degeneration.
Steffen TM; Boeve BF; Mollinger-Riemann LA; Petersen CM
Phys Ther; 2007 Aug; 87(8):1078-87. PubMed ID: 17578939
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of cortical atrophy between progressive supranuclear palsy and corticobasal degeneration by hemispheric surface display of MR images.
Taki M; Ishii K; Fukuda T; Kojima Y; Mori E
AJNR Am J Neuroradiol; 2004; 25(10):1709-14. PubMed ID: 15569735
[TBL] [Abstract][Full Text] [Related]
29. Astrocytic inclusions in progressive supranuclear palsy and corticobasal degeneration.
Yoshida M
Neuropathology; 2014 Dec; 34(6):555-70. PubMed ID: 25124031
[TBL] [Abstract][Full Text] [Related]
30. Does corticobasal degeneration exist? A clinicopathological re-evaluation.
Ling H; O'Sullivan SS; Holton JL; Revesz T; Massey LA; Williams DR; Paviour DC; Lees AJ
Brain; 2010 Jul; 133(Pt 7):2045-57. PubMed ID: 20584946
[TBL] [Abstract][Full Text] [Related]
31. Distinctive features of saccadic intrusions and microsaccades in progressive supranuclear palsy.
Otero-Millan J; Serra A; Leigh RJ; Troncoso XG; Macknik SL; Martinez-Conde S
J Neurosci; 2011 Mar; 31(12):4379-87. PubMed ID: 21430139
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic significance of tau protein in cerebrospinal fluid from patients with corticobasal degeneration or progressive supranuclear palsy.
Urakami K; Wada K; Arai H; Sasaki H; Kanai M; Shoji M; Ishizu H; Kashihara K; Yamamoto M; Tsuchiya-Ikemoto K; Morimatsu M; Takashima H; Nakagawa M; Kurokawa K; Maruyama H; Kaseda Y; Nakamura S; Hasegawa K; Oono H; Hikasa C; Ikeda K; Yamagata K; Wakutani Y; Takeshima T; Nakashima K
J Neurol Sci; 2001 Jan; 183(1):95-8. PubMed ID: 11166802
[TBL] [Abstract][Full Text] [Related]
33. Severity dependent distribution of impairments in PSP and CBS: Interactive visualizations.
Brittain C; McCarthy A; Irizarry MC; McDermott D; Biglan K; Höglinger GU; Lorenzl S; Del Ser T; Boxer AL; ; ; ;
Parkinsonism Relat Disord; 2019 Mar; 60():138-145. PubMed ID: 30201421
[TBL] [Abstract][Full Text] [Related]
34. Lateral visually-guided saccades in progressive supranuclear palsy.
Pierrot-Deseilligny C; Rivaud S; Pillon B; Fournier E; Agid Y
Brain; 1989 Apr; 112 ( Pt 2)():471-87. PubMed ID: 2706440
[TBL] [Abstract][Full Text] [Related]
35. Ocular Motor Abnormalities in Anti-IgLON5 Disease.
Macher S; Milenkovic I; Zrzavy T; Höftberger R; Seidel S; Berger-Sieczkowski E; Berger T; Rommer PS; Wiest G
Front Immunol; 2021; 12():753856. PubMed ID: 34659261
[TBL] [Abstract][Full Text] [Related]
36. Progressive supranuclear palsy and corticobasal degeneration: Diagnostic challenges and clinicopathological considerations.
Eusebio A; Koric L; Félician O; Guedj E; Ceccaldi M; Azulay JP
Rev Neurol (Paris); 2016; 172(8-9):488-502. PubMed ID: 27561438
[TBL] [Abstract][Full Text] [Related]
37. Substantia nigra in progressive supranuclear palsy, corticobasal degeneration, and parkinsonism-dementia complex of Guam: specific pathological features.
Oyanagi K; Tsuchiya K; Yamazaki M; Ikeda K
J Neuropathol Exp Neurol; 2001 Apr; 60(4):393-402. PubMed ID: 11305875
[TBL] [Abstract][Full Text] [Related]
38. Co-occurrence of radiological features of progressive supranuclear palsy and corticobasal degeneration.
Divatia R; Khan F; Kishore A
Neurol India; 2007; 55(1):75-7. PubMed ID: 17272907
[TBL] [Abstract][Full Text] [Related]
39. Behavior and cognition in corticobasal degeneration and progressive supranuclear palsy.
Kertesz A; McMonagle P
J Neurol Sci; 2010 Feb; 289(1-2):138-43. PubMed ID: 19733862
[TBL] [Abstract][Full Text] [Related]
40. Clinical and pathologic evidence of corticobasal degeneration and progressive supranuclear palsy in familial tauopathy.
Tuite PJ; Clark HB; Bergeron C; Bower M; St George-Hyslop P; Mateva V; Anderson J; Knopman DS
Arch Neurol; 2005 Sep; 62(9):1453-7. PubMed ID: 16157754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
